LF Capital Brings on BlackRock Funds as a Sponsor/Anchor Investor
by Kristi Marvin on 2018-06-14 at 1:27pm

BlackRock Funds Now Sponsoring/Anchoring Both LF Capital and VectoIQ

LF Capital Acquisition Corp., a SPAC focused on the Fintech sector, filed an amended S-1 yesterday with a few important changes.  Namely, BlackRock Funds is now part of the Sponsor Group AND they are coming on as an Anchor Investor to the tune of 1.3365 million units of the 13.5 million being offered in the IPO.  This is the second recent offering (the other being VectoIQ) that BlackRock Funds has participated in the capacity of Sponsor/Anchor in less than a month.  Plus, both SPACs have a tech focus – VectoIQ in Automotive/Transportation Tech and LF Capital in Fintech.  Sounds like BlackRock wants in on the future…

Let’s look at the details:

 

Anchor Investor (Expression of Interest)

The filing lists the section detailing the Anchor Investor purchase as an “Expression of Interest”, a term which gives BlackRock some wiggle room considering they have only “expressed an interest” in purchasing 1.3365 million units in the offering, or $13.365 million worth. However, the filing goes on to say…

“…the anchor investor has agreed with us that, if it does not own a minimum of 1,336,500 public shares (which amount will be reduced on a pro rata basis if less than 13,500,000 units are sold in this offering) at the time of any stockholder vote with respect to an initial business combination or the business day immediately prior to the consummation of our initial business combination, it will transfer to the sponsor all or a portion of the 267,300 founder shares it purchased prior to this offering on a pro rata basis.”

In layman’s terms:  BlackRock loses those valuable Founders Shares that they purchased for a paltry $1,980 (that’s not millions, that’s $1,980.00) if they own anything less than their original purchase at the business combination.

Additionally, you might be asking why 1.3365 million units? Well, that keeps the purchase under 10.0%.  Blackrock’s purchase will be 9.9% of the total units in the offering to be exact, to avoid a 13-G filing.

Founders Shares

As the part of the Sponsor group, BlackRock purchased 267,300 founders shares for $1,980. Below is the breakdown of ownership from the filing.

Beneficial Ownership of LF Capital

Private Placement Warrants

BlackRock is also participating in the Sponsor purchase of the private placement warrants.  The total private placement warrants purchase for the Sponsor group is 5,600,000 warrants at $1.00 and BlackRock’s portion is for 443,520 warrants, also at $1.00.

Summary

In summary, BlackRock Funds gives the SPAC confidence in a minimum amount in trust at business combination ($13.365 million), but it also lends the SPAC a bit of cachet, or credibility. Both of which are important at IPO and more importantly, to potential targets.  It’s a big positive for this deal.

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

by Nicholas Alan Clayton on 2024-04-16 at 7:58am

At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...

by Nicholas Alan Clayton on 2024-04-15 at 3:47pm

AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved